Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Data on the identification of VRK2 as a mediator of PD-1 function

Data in Brief(2021)10.1016/j.dib.2021.107168Source: DataRank Database

Data on the identification of VRK2 as a mediator of PD-1 function is a research paper published in Data in Brief (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Kieran Adam ORCID,Adam Mor ORCID,Michael Peled ORCID

Live enrichment

PubMed:34113705 PMC:PMC8170101 OpenAlex:https://openalex.org/W3165049257

National Institutes of Health

Grant: AI125640

National Institutes of Health

Grant: AI150597

National Institutes of Health

Grant: CA231277

NIAID NIH HHS

Grant: R01 AI125640

NIAID NIH HHS

Grant: R01 AI150597

NCI NIH HHS

Grant: R21 CA231277

National Institutes of Health

Grant: 1R21CA231277-01A1

(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade

National Institutes of Health

Grant: 5R01AI125640-09

Novel mechanisms regulating PD-1 signaling and function

National Institutes of Health

Grant: 5R01AI150597-04

PAG is a novel target in immunotherapy

Cancer Research Institute

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2352340921004522/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2352340921004522/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352340921004522?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352340921004522?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.dib.2021.107168

Fields of Study

Cell death mechanisms and regulationCancer-related Molecular PathwaysMelanoma and MAPK Pathways0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Jurkat cellsBlockadeCancer researchImmunotherapySignal transductionT cellPD-L1Small hairpin RNAEx vivoKinaseMediatorIn vivoMedicinePharmacologyGene knockdownBiologyImmune systemCell biologyImmunologyReceptorApoptosisInternal medicineBiochemistryTCRPD-1Vrk2Q1-390Science (General)Computer applications to medicine. Medical informaticsR858-859.7Data Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being